Responses
Clinical/translational cancer immunotherapy
Original research
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.